AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

KRSA

Korsana·NASDAQ
--
--(--)
--
--(--)

Korsana (KRSA) Stock Statistics, Valuation & Financial Metrics

Total Valuation

Korsana market cap is 1.54B and enterprise value is 1.53B.

Share Statistics

Korsana has 45.54M shares outstanding, with a free float of 211.04K.

Valuation Ratios

Korsana's PE ratio is -228.96, PB ratio is 301.88, and PS ratio is --, showing whether the stock looks expensive or cheap.

Solvency

Korsana debt-to-equity ratio is 0 and debt-to-assets ratio is 0.27.

Liquidity

Korsana's current ratio is 0.82, quick ratio is 0.82, and cash ratio is 0.75, showing its short-term liquidity position.

Return on Capital

Korsana's ROE is -98.22%, ROA is -82.29%, and ROIC is -99.93%, showing its return on capital profile.

ROE (TTM)
-98.22%
ROIC (TTM)
-99.93%
ROA (TTM)
-82.29%

Profitability

Korsana gross margin is --, operating margin is --, and net margin is --.

Cost Structure

Korsana spends -- of revenue on R&D and -- on SG&A.

Operating Efficiency

Korsana's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.

Revenue Per Employee
2.07M
Profits Per Employee
-3.53M

Income Statement

Korsana's revenue is --, gross profit is --, net income is -6.71M, and EBITDA is -6.82M.

Basic EPS (TTM) YoY Growth
-1157.97%

Balance Sheet

Korsana's total debt is 0, net debt is 0, total equity is 5.09M, and cash is 1.39M.

Cash Flow Statement

Korsana's operating cash flow is -4.45M, free cash flow is -4.52M, and CapEx is --.

Dividends & Yields

Korsana dividend yield is 0.00%, with a payout ratio of -- and dividend per share of --.

Analyst Rating

Korsana's latest analyst rating is Buy, with an analyst target price of --.

Analyst Rating
Buy

Company Info

Biotech company developing therapies for neurodegenerative diseases

Listing Date
2019-04-02
Employees
1

Per Share Metrics

Korsana's EPS is -8.68, book value per share is 8.37, and free cash flow per share is --.